Back to Search
MABEL DEA, PHARM.D.
PHARM.D.
Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist
NPI: 1861599326Individual
Specialties, Licenses & Credentials
Pharmacist Clinician (PhC)/ Clinical Pharmacy SpecialistPrimary
Pharmacist — Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist
Code: 1835P0018X
RPH 59407(CA)
Pharmacist
Pharmacist
Code: 183500000X
PS41634(FL)
Research & Publications (19)
Albumin binding of acylated insulin (NN304) does not deter action to stimulate glucose uptake.
PMID 11872677·Diabetes·2002
7-preclinical
Paradoxical effect of troglitazone in normal animals: enhancement of adipocyte but reduction of liver insulin sensitivity.
PMID 11118011·Diabetes·2000
7-preclinical
In vivo distribution and therapeutic efficacy of a novel amphotericin B poly-aggregated formulation.
PMID 18285313·J Antimicrob Chemother·2008
7-preclinical
HPLC assay for determination of amphotericin B in biological samples.
PMID 18059059·Biomed Chromatogr·2008
7-preclinical
Efficacy of alternative dosing regimens of poly-aggregated amphotericin B.
PMID 18534826·Int J Antimicrob Agents·2008
4-observational
Influence of the vehicle on the properties and efficacy of microparticles containing amphotericin B.
PMID 16051534·J Drug Target·2005
7-preclinical
Atypical presentation of multiple evanescent white dot syndrome involving granular lesions of varying size.
PMID 15860314·Am J Ophthalmol·2005
5-case
Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance.
PMID 15522994·Am J Physiol Endocrinol Metab·2005
7-preclinical
Treatment of experimental visceral leishmaniasis with amphotericin B in stable albumin microspheres.
PMID 15328080·Antimicrob Agents Chemother·2004
7-preclinical
Amphotericin B molecular organization as an essential factor to improve activity/toxicity ratio in the treatment of visceral leishmaniasis.
PMID 15621670·J Drug Target·2004
7-preclinical
An integrative biology approach for analysis of drug action in models of human vascular inflammation.
PMID 15208272·FASEB J·2004
8-other
Mechanism of action in dogs of slow-acting insulin analog O346.
PMID 12727983·J Clin Endocrinol Metab·2003
4-observational
Reduction of poliovirus 1, bacteriophages, Salmonella montevideo, and Escherichia coli O157:H7 on strawberries by physical and disinfectant washes.
PMID 12597475·J Food Prot·2003
8-other
Elevated glucagon-like peptide-1-(7-36)-amide, but not glucose, associated with hyperinsulinemic compensation for fat feeding.
PMID 12414891·J Clin Endocrinol Metab·2002
7-preclinical
Mode of transcapillary transport of insulin and insulin analog NN304 in dog hindlimb: evidence for passive diffusion.
PMID 11872653·Diabetes·2002
7-preclinical
Lack of hepatic "interregulation" during inhibition of glycogenolysis in a canine model.
PMID 11440915·Am J Physiol Endocrinol Metab·2001
7-preclinical
Longitudinal compensation for fat-induced insulin resistance includes reduced insulin clearance and enhanced beta-cell response.
PMID 11118015·Diabetes·2000
7-preclinical
Rapid oscillations in omental lipolysis are independent of changing insulin levels in vivo.
PMID 10930445·J Clin Invest·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5901 E 7TH ST
LONG BEACH, CA 90822 - Phone
- (562) 826-8000
Quick Facts
- NPI
- 1861599326
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 19
Are you this provider?
Claim Your Profile